A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...

As Dubai continues to strengthen its position as a global hub for longevity, health innovation and advanced medicine, Next ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

Could this work to prevent blindness and eventually turn back the clock in other organs too?

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Spinal cord injury (SCI) leads to devastating and often irreversible loss of sensory and motor function due to the limited regenerative capacity of the ...

A new book by New York Times reporters Maggie Haberman and Jonathan Swan claims JD Vance suggested India and Saudi Arabia as ...